Get the Stockscreener App
4.41
9.07%
-0.44
After Hours:
4.42
0.010
+0.23%
Protara Therapeutics Inc Stock (TARA) Forecast
The Protara Therapeutics Inc (TARA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $22.63, representing a +413.12% increase from the current price of $4.41. The highest analyst price target is $29.90, and the lowest is $15.36.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TARA Price Target
Average 32.21
(+630.29% Upside)
Is Protara Therapeutics Inc (TARA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.97 | Neutral |
| STOCH(9,6) | 67.50 | Neutral |
| STOCHRSI(14) | 0.9447 | Buy |
| MACD(12,26) | -0.059 | Sell |
| ADX(14) | 17.50 | Neutral |
| William %R | -88.54 | Buy |
| CCI(14) | -21.76 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.721
Sell
|
4.7676
Sell
|
| MA20 |
4.7825
Sell
|
4.8377
Sell
|
| MA50 |
4.9538
Sell
|
4.5911
Sell
|
| MA100 |
3.5251
Buy
|
3.9622
Buy
|
| MA200 |
2.9736
Buy
|
3.3276
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, TARA could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 7 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on TARA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.97 indicates that TARA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 67.5 indicates that TARA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0.9447 indicates that TARA is oversold. This suggests that TARA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.5 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -21.76 indicates that TARA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TARA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Protara Therapeutics Inc financial reports and earnings history, Protara Therapeutics Inc (TARA) stock could reach $7.3178 by 2030, $9.838 by 2040 and $27.25 by 2050. See the projected annual prices until 2050 of the Protara Therapeutics Inc stock below:
- Protara Therapeutics Inc (TARA) is expected to reach an average price of $5.2179 in 2035, with a high prediction of $5.3765 and a low estimate of $5.33. This indicates an $18.32% rise from the last recorded price of $4.41.
- Protara Therapeutics Inc (TARA) stock is projected to chart a bullish course in 2040, with an average price target of $9.6215, representing an $118.17% surge from its current level. The forecast ranges from a conservative $9.7835 to a sky-high $9.838.
- Our analysts predict Protara Therapeutics Inc (TARA) to jump 302.36% by 2045, soaring from $18.08 to an average price of $17.74, potentially reaching $17.59. While $18.08 is the low estimate, the potential upside is significant.
- Protara Therapeutics Inc (TARA) stock is expected to climb by 2050, reaching an average of $26.61, a $503.34% jump from its current level. However, a wide range of estimates exists, with high and low targets of $27.25 and $27.32, respectively, highlighting the market's uncertainty.
Protara Therapeutics Inc Stock (TARA) Year by Year Forecast
Protara Therapeutics Inc Stock (TARA) Price Forecast for 2025
Protara Therapeutics Inc Stock (TARA) is expected to reach an average price of $29.08 in 2025, with a high prediction of $57.54 and a low estimate of $0.6176. This indicates an +559.33% rise from the last recorded price of $4.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $18.46 | $15.36 | $29.90 | +318.58% |
| April, 2025 | $13.11 | $9.3038 | $20.27 | +197.39% |
| May, 2025 | $14.21 | $10.48 | $15.16 | +222.20% |
| June, 2025 | $14.41 | $11.34 | $18.25 | +226.84% |
| July, 2025 | $25.52 | $12.97 | $57.54 | +478.66% |
| August, 2025 | $18.06 | $16.03 | $30.84 | +309.59% |
| September, 2025 | $16.95 | $14.69 | $27.43 | +284.34% |
| October, 2025 | $10.64 | $9.3328 | $17.50 | +141.33% |
| November, 2025 | $7.8771 | $6.8761 | $13.13 | +78.62% |
| December, 2025 | $9.1425 | $7.7782 | $14.27 | +107.31% |
Protara Therapeutics Inc Stock (TARA) Price Forecast for 2026
The predicted value for Protara Therapeutics Inc (TARA) in 2026 is set at an average of $9.4925. Estimates vary from a peak of $18.96 to a trough of $0.0277, indicating an +115.25% surge from the present price of $4.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $14.53 | $8.2336 | $16.79 | +229.41% |
| February, 2026 | $16.66 | $12.46 | $18.96 | +277.80% |
| March, 2026 | $10.99 | $10.93 | $16.91 | +149.10% |
| April, 2026 | $13.54 | $8.7186 | $14.71 | +207.05% |
| May, 2026 | $9.0551 | $4.3029 | $13.76 | +105.33% |
| June, 2026 | $6.9294 | $5.2572 | $9.5511 | +57.13% |
| July, 2026 | $1.1447 | $0.6747 | $9.6604 | -74.04% |
| August, 2026 | $2.2191 | $1.1158 | $3.328 | -49.68% |
| September, 2026 | $1.4044 | $0.9144 | $3.2712 | -68.15% |
| October, 2026 | $0.0587 | $0.0277 | $1.5855 | -98.67% |
| November, 2026 | $1.053 | $0.4892 | $1.293 | -76.12% |
| December, 2026 | $0.2616 | $0.2941 | $1.1941 | -94.07% |
Protara Therapeutics Inc Stock (TARA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Protara Therapeutics Inc (TARA) is $1.3574, with a high forecast of $2.6818 and a low forecast of $0.033. This indicates an -69.22% decrease from the last price of $4.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.3073 | $0.4505 | $0.8616 | -93.03% |
| February, 2027 | $0.267 | $0.033 | $1.0059 | -93.95% |
| March, 2027 | $0.1076 | $0.2019 | $0.5781 | -97.56% |
| April, 2027 | $0.2833 | $0.3265 | $0.4655 | -93.58% |
| May, 2027 | $1.039 | $1.269 | $1.2601 | -76.44% |
| June, 2027 | $2.0436 | $1.5879 | $1.6348 | -53.66% |
| July, 2027 | $1.1393 | $1.2093 | $1.7527 | -74.16% |
| August, 2027 | $1.705 | $1.1983 | $1.305 | -61.34% |
| September, 2027 | $2.4797 | $2.499 | $2.6818 | -43.77% |
| October, 2027 | $2.7253 | $2.6264 | $2.575 | -38.20% |
| November, 2027 | $2.321 | $2.7143 | $2.3722 | -47.37% |
| December, 2027 | $2.0557 | $2.4657 | $2.3789 | -53.39% |
Protara Therapeutics Inc Stock (TARA) Price Forecast for 2028
In 2028, Protara Therapeutics Inc (TARA) is projected to reach an average price of $1.5656, with a high projection of $2.1295 and a low estimate of $1.0017. This indicates an -64.50% fall from the last price of $4.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.2114 | $2.1224 | $1.9814 | -49.86% |
| February, 2028 | $2.3571 | $1.9992 | $1.6421 | -46.55% |
| March, 2028 | $2.0917 | $1.9828 | $1.9317 | -52.57% |
| April, 2028 | $1.4174 | $1.9074 | $2.1295 | -67.86% |
| May, 2028 | $2.112 | $1.6152 | $1.8321 | -52.11% |
| June, 2028 | $1.7977 | $1.7977 | $1.9709 | -59.24% |
| July, 2028 | $1.3334 | $1.4445 | $1.4306 | -69.76% |
| August, 2028 | $1.218 | $1.0017 | $1.2073 | -72.38% |
| September, 2028 | $1.2837 | $1.2159 | $1.0537 | -70.89% |
| October, 2028 | $1.1494 | $1.2549 | $1.1927 | -73.94% |
| November, 2028 | $1.174 | $1.1673 | $1.1311 | -73.38% |
| December, 2028 | $1.5597 | $1.2919 | $1.4097 | -64.63% |
Protara Therapeutics Inc Stock (TARA) Price Forecast for 2029
The 2029 price forecast for Protara Therapeutics Inc Stock (TARA) is $2.7256 on average, with a high prediction of $5.34 and a low estimate of $0.1111. This represents an -38.20% decrease from the previous price of $4.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.2044 | $1.2344 | $1.4387 | -72.69% |
| February, 2029 | $1.4501 | $1.4033 | $1.2911 | -67.12% |
| March, 2029 | $1.6958 | $1.4668 | $1.3929 | -61.55% |
| April, 2029 | $1.7715 | $1.8736 | $1.7336 | -59.83% |
| May, 2029 | $2.0761 | $2.0004 | $2.0482 | -52.92% |
| June, 2029 | $1.7068 | $1.7419 | $1.9839 | -61.30% |
| July, 2029 | $1.1424 | $1.2575 | $1.4919 | -74.10% |
| August, 2029 | $0.3121 | $0.3821 | $0.7514 | -92.92% |
| September, 2029 | $1.4722 | $0.1111 | $1.6822 | -66.62% |
| October, 2029 | $1.4376 | $0.7865 | $2.2433 | -67.40% |
| November, 2029 | $0.1819 | $0.1519 | $2.7197 | -95.88% |
| December, 2029 | $8.54 | $0.3229 | $5.34 | +93.65% |
Protara Therapeutics Inc Stock (TARA) Price Forecast for 2030
Protara Therapeutics Inc Stock (TARA) is expected to reach an average price of $11.14 in 2030, with a high forecast of $22.10 and a low forecast of $0.1732. This signifies an +152.51% surge from the last price of $4.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.8292 | $6.5314 | $7.3178 | +32.18% |
| February, 2030 | $4.3406 | $6.0428 | $4.2249 | -1.57% |
| March, 2030 | $7.532 | $5.9185 | $6.852 | +70.79% |
| April, 2030 | $9.0834 | $10.04 | $9.4077 | +105.97% |
| May, 2030 | $11.17 | $8.3991 | $10.77 | +153.35% |
| June, 2030 | $11.12 | $11.31 | $10.31 | +152.25% |
| July, 2030 | $8.6133 | $10.21 | $10.62 | +95.31% |
| August, 2030 | $9.5647 | $9.1469 | $7.9647 | +116.89% |
| September, 2030 | $9.4839 | $2.5161 | $21.46 | +115.05% |
| October, 2030 | $16.66 | $2.096 | $22.10 | +277.88% |
| November, 2030 | $6.5432 | $0.1732 | $18.08 | +48.37% |
| December, 2030 | $3.3318 | $0.2046 | $9.3354 | -24.45% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):